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Non-technical summary The islet of Langerhans secretes the hormone insulin in response to
elevated glucose. Interactions between cells within the islet is important for the regulation of
insulin secretion, to both suppress basal insulin secretion and enhance the glucose-stimulated
response. We show that multiple mechanisms of cell–cell communication are required for the
suppression of basal insulin release. First, gap junctions suppress spontaneous calcium signals
which suppresses triggering of insulin release. Second, other juxtacrine mechanisms, regulated
by cAMP and glucose, suppress more distal steps in the regulation of insulin granule exocytosis.
Eachmechanism is sufficiently robust to compensate for a loss of the other and still fully suppress
basal insulin release. This new insight into the function of islet of Langerhans is important for
understanding the development and treatment of diabetes.
Abstract Cell–cell communication in the islet of Langerhans is important for the regulation of
insulin secretion. Gap-junctions coordinate oscillations in intracellular free-calcium ([Ca2+]i)
and insulin secretion in the islet following elevated glucose. Gap-junctions can also ensure that
oscillatory [Ca2+]i ceases when glucose is at a basal levels.We determine the roles of gap-junctions
and other cell–cell communication pathways in the suppression of insulin secretion under basal
conditions. Metabolic, electrical and insulin secretion levels were measured from islets lacking
gap-junction coupling following deletion of connexion36 (Cx36−/−), and these results were
compared to those obtained using fully isolated β-cells. KATP loss-of-function islets provide a
further experimental model to specifically study gap-junction mediated suppression of electrical
activity. In isolatedβ-cells or Cx36−/− islets, elevations in [Ca2+]i persisted in a subset of cells even
atbasal glucose. Isolatedβ-cells showedelevated insulin secretionatbasal glucose; however, insulin
secretion from Cx36−/− islets was minimally altered. [Ca2+]i was further elevated under basal
conditions, but insulin release still suppressed in KATP loss-of-function islets. Forced elevation
of cAMP led to PKA-mediated increases in insulin secretion from islets lacking gap-junctions,
but not from islets expressing Cx36 gap junctions. We conclude there is a redundancy in how
cell–cell communication in the islet suppresses insulin release. Gap junctions suppress cellular
heterogeneity and spontaneous [Ca2+]i signals, while other juxtacrine mechanisms, regulated by
PKA and glucose, suppress more distal steps in exocytosis. Each mechanism is sufficiently robust
to compensate for a loss of the other and still suppress basal insulin secretion.
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Introduction
The pancreatic islets of Langerhans play a central role
in the regulation of blood glucose homeostasis through
the regulated secretion of the hormones insulin and
glucagon. Glucose-stimulated insulin secretion (GSIS)
from β-cells is regulated by a series of molecular
events including an elevated ATP/ADP ratio following
glucose metabolism, subsequent ATP-sensitive K+ (KATP)
channel closure, membrane depolarization, Ca2+ influx
to increase intracellular free-calcium activity ([Ca2+]i),
and the triggering of insulin granule exocytosis. Other
important steps independent of this ‘KATP-dependent’
or ‘triggering pathway’ include cAMP elevations which
elevate insulin granule trafficking to theplasmamembrane
and amplify exocytosis (Henquin, 2000). The ability of
endocrine cells within the islet to communicate with
one another is an important factor for the regulation
of insulin secretion (Halban et al. 1982). Thus, in intact
islets, the dynamic range of GSIS from β-cells is enhanced
many-fold compared to the responses observed from iso-
latedβ-cells (Lernmark, 1974;Halban et al.1982): in intact
islets, β-cells exhibit both reduced insulin secretion at low
glucose and enhanced insulin secretion at elevated glucose.
Isolated β-cells also exhibit heterogeneous and irregular
responses to glucose for many variables (Pipeleers, 1992),
including NAD(P)H elevations (Bennett et al. 1996),
oscillations in [Ca2+]i (Zhang et al. 2003), and the levels
of insulin release (Vanschravendijk et al. 1992). Therefore
understanding how cells communicate within the intact
islet is important to understand precisely how insulin
secretion is regulated.
Gap junction channels formed by connexin36 (Cx36)
couple β-cells in the islet (Theis et al. 2004; Moreno
et al. 2005), which can mediate ionic currents and
the diffusion of small molecules (Quesada et al. 2003;
Charpantier et al. 2007). As a result, Cx36 gap junctions
are important for coordinating the oscillatory dynamics
of membrane depolarization and [Ca2+]i (Calabrese et al.
2003; Ravier et al. 2005; Benninger et al. 2008) and
for generating pulsatile insulin secretion (Ravier et al.
2005). Additionally, Cx36 gap junctions are important to
ensure that there is uniform suppression of spontaneous
membrane depolarizations and [Ca2+]i bursts that
can occur in a subpopulation of β-cells, as a result
of cellular differences in KATP channel activity and
other heterogeneous processes of the β-cell. This is
especially the case following expression of a KATP channel
loss-of-function mutation (Rocheleau et al. 2006), or
following KATP channel inhibition with ATP (Speier et al.
2007). This has led to a model whereby the less excitable
β-cells in the islet can suppress, via gap junctions,
spontaneous electrical activity induced in neighbouring,
excited β-cells, (Rocheleau et al. 2006).
The subsequent impact of this regulatory mechanism
on physiological insulin secretion is less clear. Thus,
Rupnik and colleagues showed that in the absence of
Cx36, when switching from high to low glucose the
switch-off of insulin secretion is less rapid (Speier et al.
2007), suggesting that Cx36 can at least transiently
suppress insulin release. However, Meda and colleagues
showed that only minimal changes in insulin secretion
occur at low glucose levels (their Fig. 7C), despite a
more significant increase in [Ca2+]i (their Fig. 7A) seen
following the knockout of Cx36 (Ravier et al. 2005).
Therefore, additional mechanistic understanding of the
role of islet gap junction coupling in the regulation of
basal insulin secretion is needed.
In addition to gap junctions, other juxtacrine
mechanisms dependent on cell–cell contact may also help
to regulate insulin release. EphA–ephrinA bi-directional
signalling between β-cells (Konstantinova et al. 2007)
has been suggested to regulate remodelling of the
cortical F-actin network, which affects distal points in
the GSIS pathway to regulate insulin release, including
insulin granule trafficking and docking to the plasma
membrane. Similarly, neuronal cell-adhesion molecule
(NCAM) between β-cells has also been suggested to
regulate the cortical F-actin network and insulin secretion
(Olofsson et al. 2009). Therefore understanding the role of
juxtacrinemechanisms and how they do or do not interact
with gap junctions still needs to be determined.
In this study, we sought to discover the role of gap
junction coupling in regulating the suppression of insulin
secretion at low glucose in intact islets. We also asked how
gap junction coupling quantitatively compares with other
mechanisms dependent on cell–cell contact in regulating
this suppression, by comparing intact islets lacking gap
junctionswith dissociated isolatedβ-cells.We testwhether
the disruptionof gap junction coupling alone recapitulates
the behaviour of dissociated β-cells, or whether other
mechanisms dependent on cell–cell contact may persist
despite eliminationof the gap junctionmediated coupling.
To test this, we quantify islet metabolic, electrical as well
as insulin secretory responses to glucose. We also utilize
islets in which electrical activity has been perturbed by
the mosaic expression of a loss-of-function mutation in
KATP channels (Koster et al. 2000; Rocheleau et al. 2006). In
this mouse model, elevations of basal [Ca2+]i and insulin
secretion due to the KATP loss-of-function are suppressed
bymechanismsdependent on cell–cell contact in the intact
islet. These islets therefore allow us to specifically study
how cellular differences in electrical activity in the intact
islet are suppressed by gap junction coupling and other
mechanism dependent on cell–cell contacts, as well as to
understand how these mechanisms suppress basal insulin
secretion.
C© 2011 The Authors. Journal compilation C© 2011 The Physiological Society
J Physiol 589.22 Cell–cell communication in basal insulin secretion 5455
Methods
Ethical approval
All experiments were performed in compliance with
relevant laws and institutional guidelines, and were
approved by Vanderbilt University Institutional Animal
Care and Use Committee. The authors have read, and the
experiments comply with the policies and regulations of
The Journal of Physiology given by Drummond (2009).
Animal care
Mice were housed in a temperature controlled facility
with 12 h light–dark cycle and access to food and water
ad libitum. Generation of Cx36-LacZ knockout mice
(Cx36−/−) is described by Degen et al. (2004). Generation
of Kir6.2[AAA] transgenic mice is described by Koster
et al. (2000).Mice were genotyped by PCR and gel electro-
phoresis using primers described in Koster et al. (2000)
and Degen et al. (2004).
Islet isolation
Islets were isolated by established protocols (Scharp
et al. 1973; Koster et al. 2002) from pancreata of 12-
to 24-week-old mice. Mice were anaesthetized under
I.P. injection of ketamine and xylazine (4.16mg and
0.84mg respectively) and killed by cervical dislocation
prior to pancreas dissection. Following isolation, islets
were maintained in RPMI-1640 medium containing 10%
fetal bovine serum, 11mM glucose, 100 Uml−1 penicillin,
100μgml−1 streptomycin, at 37◦C under humidified 5%
CO2 for 24–48 h before imaging. To obtain dissociated
β-cells, islets were washed in Ca2+-free Hanks’ balanced
salt solution, then incubated with Trypsin–EDTA (both
0.01%) at 37◦C for ∼5min. Trypsin treated islets were
dispersed by gently resuspending in islet medium, then
platedonglass coverslips in 8-well plates (from15 islets per
well) andmaintained for 24–48 h at 37◦C, 5%CO2. Single
isolated cells constituted 92± 4% of dissociated islets,
with a mean nearest-neighbour separation of ∼60μm.
Of dissociated islet cells 97.4± 1.5% were viable, assessed
by propidium iodide exclusion and AM-dye activation.
Electrophysiology
Measurements of β-cell junctional conductance were
performed as described in Mears et al. (1995) and
Sherman et al. (1995). Isolated islets were perfused with
an extracellular solution containing 115mM NaCl, 5 mM
KCl, 3 mM CaCl2, 2 mM MgCl2, 10 mM Hepes, 2 mM
glucose, pH 7.2. Membrane potential and current were
monitored using the perforated-patch method (Zhang
et al. 2003). Pipettes were filled with an intracellular
solution containing 11.8 mM NaCl, 28.4 mM K2SO4,
63.7 mM KCl, 1 mM MgCl2, 20.8 mM Hepes, 0.5 mM
EGTA, pH 7.2, plus 0.1 mgml−1 amphotericin-B. After
obtaining a gigaohm seal on a patched peripheral
β-cell, glucose levels were stepped from 2mM to 11mM.
Membrane potential was recorded in current clampmode,
then coupling current was measured in voltage clamp
mode at –65mV. The coupling conductance (g coup) was
determined by the change in coupling current (I coup)
divided by the change in membrane potential (V ).
Hormone secretion
Following overnight incubation, islets (10 per column) or
dispersed cells (from 15 islets per well) were pre-incubated
in Krebs–Ringer buffer (128.8 mM NaCl, 5 mM NaHCO3,
5.8 mM KCl, 1.2 mM KH2PO4, 2.5CaCl2, 1.2 mM MgSO4,
10mM Hepes, 0.1% BSA, pH 7.4) plus 2 mM glucose for
60min at 37◦C, then incubated for 60min at 37◦C in
Krebs–Ringer buffer plus different glucose concentrations
and/or reagents as indicated. After the incubation period,
the medium was removed and assayed for insulin release.
To estimate insulin content, islets were lysed in 1%
Triton X-100 and frozen at –20◦C overnight. Insulin
concentrations were measured by rat-insulin radio-
immunoassay.
Fluorescence microscopy and image analysis
All imaging experiments anddata analysis were performed
using published procedures (see e.g. Rocheleau et al. 2006;
Benninger et al. 2011).
To measure [Ca2+]i dynamics, isolated islets or
dispersed β-cells were loaded for 1.5 h with 4μM
Fluo4-AM (Invitrogen) at room temperature, in imaging
medium (125mM NaCl, 5.7 mM KCl, 2.5CaCl2, 1.2 mM
MgCl2, 10 mM Hepes, 2 mM glucose 0.1% BSA, pH 7.4),
then equilibrated at 37◦C for 10min. Intact islets were
imaged in a polydimethylsiloxane (PDMS) microfluidic
flow device (Rocheleau et al. 2006). Dispersed β-cells
were imaged in labtex dishes (Nunc). Islets or β-cells
were imaged on an LSM5Live or LSM510-Meta micro-
scope (Zeiss) with a 20× 0.8NA Fluar objective, using a
humidified temperature controlled chamber, maintained
at 37◦C. A series of images were acquired 10min or 60min
after application of each glucose level studied, for 10min
duration. Fluo4 fluorescence was detected using a 488 nm
diode laser for excitation and a 495–555 nm band-pass
filter to detect fluorescence emission.
To measure the absolute mean [Ca2+]i concentration,
islets were loaded for 30min with 2μM Fura2-AM
(Invitrogen), equilibrated at 37◦C for 10min, then imaged
in a microfluidic device on a TE-300 widefield micro-
scope (Nikon) with a 20× 0.45NA Fluar objective, at
C© 2011 The Authors. Journal compilation C© 2011 The Physiological Society
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37◦C. Images were acquired 10min after application of
each glucose level studied. Islets were sequentially excited
at 340 nm and 380 nm (±10 nm band-pass filter), and
fluorescence detected with a 470–550 nm band-pass filter.
Background fluorescence was measured from unstained
islets. The 340 nm and 380 nm fluorescence images were
background subtracted and averaged across each islet
studied. The 340 nm/380 nm fluorescence ratio was then
calibrated according to the Fura2 Calcium Calibration Kit
(Invitrogen) instructions.
To measure NAD(P)H, islets were incubated for
1.5 h, then imaged in a microfluidic device on an
LSM510-Meta microscope with a 40× 1.3NA Fluar
oil-immersion objective, at 37◦C. NAD(P)H auto-
fluorescence was detected using a 710 nm mode-locked
Ti:sapphire laser (Chameleon, Coherent, Santa Clara, CA,
USA) for two-photon excitation, and custom 380–550 nm
band-pass filter (Chroma, Brattleboro, VT, USA) and
non-descanned detector for emission. Z-stacks of 6 images
were acquired at 2μm spacing. All microscope and
laser settings were kept constant between experiments.
The NAD(P)H fluorescence intensity was averaged across
each islet and each z-position. The mean NAD(P)H
fluorescence intensity was normalized to that measured
in Cx36+/+ islets at 2 mM glucose.
All image analysis was performed in Matlab (The
Mathworks, Natick, MA, USA) and Image Examiner
(Zeiss). To calculate the proportion of the islet showing
[Ca2+]i bursts, the Fluo4 time course of 5 min duration
was examined on a cell-by-cell basis. An electrically active
area was defined as showing variations in the fluorescence
intensity >3 standard deviations above that calculated in
silent cells at 2 mM glucose. The proportion of the islet
showing [Ca2+]i bursts was defined as the total electrically
active area as a proportion of the total islet area. A small
number of cells (5–10%) which were active at low glucose
and were no longer active at elevated glucose are likely
α-cells (Quesada et al. 2006), and were discounted from
subsequent analysis (e.g. Fig. 1D).
Data are presented as means± SEM. Student’s t test for
paired or unpaired data was used as appropriate to assess
significance between data in each experimental group,
as indicated in figure captions. The difference in means
± 95% confidence level was calculated where indicated,
and are displayed in Supplemental Fig. S2.
Results
Dependence of islet [Ca2+]i on gap junctions and
mechanisms dependent on cell–cell contact
In isolated islets of homozygous connexin36-LacZ
knockout mice (Cx36−/−) (Degen et al. 2004) LacZ was
uniformly expressed, and islet architecture was unaltered,
with α-cells remaining on the islet mantle, and β-cells
forming the core (not shown). To confirm the absence
of functional gap junction channels, electrical coupling
between β-cells was measured using patch clamping
(Fig. 1A). β-Cells in wild-type Cx36+/+ islets had a mean
junctional conductance of 950± 96 pS, which is reduced
to 53.6± 8.2% in Cx36+/− islets and to 5.5± 2.2% in
Cx36−/− islets (Benninger et al. 2008).
Cx36−/− islets lacked synchronous andwell coordinated
oscillations in intracellular free-calcium activity ([Ca2+]i),
as previously established (Ravier et al. 2005; Benninger
et al. 2008). We quantified [Ca2+]i in Cx36+/+ and
Cx36−/− islets at a range of glucose concentrations by
measuring the proportion of islet cells that exhibit [Ca2+]i
bursts (Fig. 1B). At 2 mM glucose most β-cells were silent
in both Cx36+/+ and Cx36−/− islets. At 5.5 mM glucose
we observed similar results to 2mM glucose in Cx36+/+
islets, but in Cx36−/− islets ∼50% of the β-cells exhibited
spontaneous [Ca2+]i bursts under what is usually a sub-
threshold condition. Similar [Ca2+]i bursts were observed
either 10 or 60min after switching to 5.5 mM glucose
(not shown). Similarly, in 5.5 mM glucose, there was a
significant elevation in the absolute [Ca2+]i concentration
(Fig. 1C). Figure 1D shows representative measurements
of [Ca2+]i bursts in Cx36+/+, Cx36+/− and Cx36−/− islets
bathed in 5.5 mM glucose. The mostly quiescent [Ca2+]i
activity observed in Cx36+/+ islets contrasts strongly with
our observation of [Ca2+]i bursts inCx36+/− andCx36−/−
islets, and marked variations in the pattern of oscillations
were observed between cells. At 11mM or 20mM glucose,
a similar proportion of islet cells exhibited [Ca2+]i bursts
in Cx36+/+ and Cx36−/− islets (Fig. 1B); however the
[Ca2+]i concentrationwas reduced in the Cx36−/− islets at
20mMglucose.Dissociated isolatedβ-cells showed similar
response to intact Cx36−/− islets, namely an elevated
[Ca2+]i between 2mM and 5.5 mM glucose in a proportion
of cells (Fig. 1E).
Glucose metabolism in Cx36−/− islets was assessed
using two-photon excitation imaging of NAD(P)H. There
was no significant difference in the glucose-stimulated
NAD(P)H response (Fig. 2A) and NAD(P)H levels
(Fig. 2B) between Cx36+/+ and Cx36−/− islets. Therefore
a loss of islet gap junction mediated electrical coupling
leads to elevated [Ca2+]i at basal glucose levels, which is
similar to what is observed in dissociated β-cells that lack
any cell–cell contacts. This effect is independent of more
proximal changes in glucose metabolism.
Insulin secretion dependence on gap junctions and
mechanisms dependent on cell–cell contact
To study the impact of the altered [Ca2+]i on the function
of Cx36−/− islets, we measured insulin secretion over a
range of glucose concentrations. Similar levels of insulin
secretion were found in Cx36+/+, Cx36+/− and Cx36−/−
islets for all levels of glucose applied (Fig. 3A). Insulin
C© 2011 The Authors. Journal compilation C© 2011 The Physiological Society
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content per islet was not significantly different (Fig. 3B).
Transient changes in insulin secretion when switching to
low glucose can occur following a disruption of Cx36
gap junctions (Speier et al. 2007). We therefore compared
the role of gap junctions on steady-state insulin secretion
levels with cell–cell contact-dependent mechanisms, by
measuring insulin secretion in both intact and dissociated
Cx36+/+ and Cx36−/− islets. The fold response in insulin
secretion between 2mM glucose and 20mM glucose was
reduced in dissociated β-cells compared to intact islets
(Fig. 3C), with no difference comparing either intact
Cx36+/+ and Cx36−/− islets or dissociated Cx36+/+
and Cx36−/− β-cells. In both Cx36+/+ and Cx36−/−
islets, dissociated isolated β-cells showed elevated insulin
secretion compared to intact islets at 2 mM and 5.5 mM
glucose (Fig. 3D and E, respectively). No difference was
observed at 11mM or 20mM glucose. Therefore a loss of
islet gap junction mediated electrical coupling alone has
a negligible impact on insulin secretion compared to the
elevated basal insulin secretion observed from dissociated
β-cells that lack any cell–cell contact. This is despite the
elevated [Ca2+]i that is observed in each case.
A B C
D E
2 5 11 20
0.0
0.1
0.2
0.3
 Glucose (mM) 
[Ca
2+
] ( iµ
M
)
Cx36+/+
Cx36-/-
+/+ +/- -/-
0.0
0.2
0.4
0.6
0.8
1.0
1.2
 Cx36
Co
up
lin
g c
on
du
cta
nc
e 
(nS
)
0 5 10 15 20
0
20
40
60
80
100
%
 
ce
lls
 
[Ca
2+
] a
ct
ivi
ty 
i
Glucose (mM)
Cx36+/+ intact
Cx36+/+ disp.
**
**
*
0 60 120 180 240 300
Fl
uo
-4
 F
luo
re
sc
en
ce
 (n
or
m
.
)
Time (sec.) 0 120 240 360 480 600Time (sec.)
0 120 240 360 480 600
Time (sec.)
Cx36+/+ Cx36+/- Cx36-/-
0 5 10 15 20
0
20
40
60
80
100
%
 
ce
lls
 
[Ca
2+
] a
ct
ivi
ty 
i
Glucose (mM)
Cx36+/+ intact
Cx36-/- intact
*
1
2
3
4
1
2
3
4
5
6
1
2
3
4
5
Figure 1. Glucose-dependent [Ca2+]i in Cx36−/− islets
A, mean coupling conductance of peripheral islet β-cells during single-cell current and voltage clamp recording.
Measurements were made in islets isolated from Cx36+/+, Cx36+/− and Cx36−/− mice, from 3 mice for each
group. B, mean percentage of cells displaying dynamic changes in [Ca2+]i as a function of glucose stimulation
for intact Cx36+/+ islets (filled squares) and Cx36−/− islets (open squares). Data averaged over n = 5 mice.
∗∗Significant difference of P < 0.01 (Student’s unpaired t test) at each glucose concentration comparing intact
Cx36+/+ and Cx36−/− islet data. C, mean [Ca2+]i as a function of glucose stimulation for intact Cx36+/+ islets
(filled bars) and Cx36−/− islets (open bars). Data averaged over n = 7 mice. ∗Significant difference of P < 0.05
(Student’s paired t test) comparing each experimental group as indicated. D, representative time courses of [Ca2+]i
at 5.5 mM glucose, as measured from Fluo4 fluorescence, for a number of non-adjacent cells (numbered) from a
single Cx36+/+, Cx36+/− and Cx36−/− islet as indicated. Time courses are offset for clarity and vertical scale bar
indicates 2-fold change in Fluo4 fluorescence. Time course 1 in Cx36+/+ (in grey) represents a cell showing no
activity at elevated glucose and therefore classified as an α-cell. E, mean percentage of cells displaying dynamic
changes in [Ca2+]i as a function of glucose stimulation for intact wild-type islets (black squares) and dissociated
wild-type cells (grey triangles). Data averaged over n = 3 mice. ∗∗Significant difference of P < 0.01 (Student’s
unpaired t test) at each glucose concentration comparing intact islet and dissociated cell data. The difference in
means ± 95% confidence interval for C is shown in Fig. S2A.
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autofluorescence as a function of glucose
stimulation, for islets isolated from Cx36+/+
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Figure 3. Insulin secretion in Cx36−/− islets and dissociated β-cells
A, glucose-stimulated insulin secretion from isolated islets of Cx36+/+ (black squares), Cx36+/− (grey squares),
Cx36−/− (open squares) mice. B, insulin content of Cx36+/+, Cx36+/− and Cx36−/− islets. Data in A and B
averaged over n = 7 mice for each group. C, mean fold-increase in insulin secretion between 2 mM and 20 mM
glucose stimulation for intact Cx36+/+ and Cx36−/− islets and dissociated (disp.) Cx36+/+ and Cx36−/− β-cells.
∗Significant difference of P < 0.05 (Student’s paired t test) comparing each experimental group as indicated.
D, glucose-stimulated insulin secretion from intact Cx36+/+ islets (black squares) and dissociated Cx36+/+
β-cells (grey triangles), displayed as fractional insulin secretion per hour normalized by insulin content. E,
glucose-stimulated insulin secretion from intact Cx36−/− islets (open squares) and dissociated Cx36−/− β-cells
(open triangles). Measurements for all groups in C, D and E made in parallel experiments, averaged over n = 11
littermate Cx36+/+ and Cx36−/− mice for each group. ∗Significant difference of P < 0.05 (Student’s paired t test)
at each glucose concentration comparing intact islet and dissociated cell data. The difference in means ± 95%
confidence interval for D and E is shown in Fig. S2B.
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Elevation in [Ca2+]i, but not insulin secretion, in KATP
loss-of-function islets lacking gap junctions
So far we have found that in intact Cx36−/− islets, the
elevated [Ca2+]i at low glucose is similar to dissociated
β-cells. However, insulin secretion is unchanged, in
contrast to the elevated insulin secretion seen at low
glucose and the reduced fold-response in isolated β-cells.
To further test these divergent [Ca2+]i and insulin
response, we studied the role of Cx36 gap junctions
in islets of mice that have a loss-of-function to the
KATP channel, via expression of a dominant-negative
mutant-Kir6.2 subunit (Kir6.2[AAA]; Koster et al. 2002).
This mutation renders the pore-forming subregion of
the channel non-functional, essentially eliminating KATP
conductance independent of glucose. Therefore increased
variation in cellular electrical activity occurs, defined by
the penetrance of the Kir6.2[AAA] transgene (visualized
by a GFP tag). Isolated β-cells of Kir6.2[AAA] islets
exhibit elevated and largely glucose-independent [Ca2+]i
and insulin secretion responses, as expected given the
substantial reduction in KATP conductance. However,
within intact Kir6.2[AAA] islets, β-cells exhibit essentially
normal [Ca2+]i and insulin secretion responses to glucose
(Rocheleau et al. 2006). Therefore themaintained cell–cell
contacts in these islets robustly suppresses the expected
elevations in [Ca2+]i and insulin release at low glucose
due to the KATP mutation. These islets therefore allow us
to quantify and further distinguish how gap junctions and
other means of cell–cell communication can specifically
regulate basal electrical activity and insulin secretion in the
intact islet. They also allow us to determine how insulin
secretionmay be suppressed by cell–cell contacts in amore
mechanistic manner.
We therefore crossed Kir6.2[AAA] transgenic mice
with Cx36−/− mice. At glucose concentrations ranging
from 2 to 6mM, there was a substantial increase
in [Ca2+]i bursts observed in Kir6.2[AAA]:Cx36−/−
islets compared to more typically quiescent [Ca2+]i
changes observed in Kir6.2[AAA]:Cx36+/+ and WT
control islets (Fig. 4A). Kir6.2[AAA]:Cx36+/− islets
exhibited an intermediate number of [Ca2+]i bursts
(Fig. 4B), indicating a progressive increase in [Ca2+]i
activity as the level of electrical coupling is
gradually reduced (Supplemental Fig. S1). Similarly, in
Kir6.2[AAA]:Cx36−/− islets, the [Ca2+]i concentration
observed at 2 mM glucose was significantly increased,
while the [Ca2+]i concentration at 20mM glucose was
significantly reduced (Fig. 4C). Isolatedβ-cells dissociated
from Kir6.2[AAA]:Cx36+/+ or Kir6.2[AAA]:Cx36−/−
islets exhibited similar glucose-stimulated [Ca2+]i
responses (Fig. 4D and E), with elevated [Ca2+]i at 2 mM
glucose restricted to GFP+ cells expressing the mutant
Kir6.2[AAA] transgene.
We next determined if the altered [Ca2+]i
observed in the absence of Cx36 impacts insulin
secretion in Kir6.2[AAA] islets. GSIS observed in
Kir6.2[AAA]:Cx36−/− islets is slightly left shifted to
glucose compared to control transgenic islets, but there
was no significant difference measured at 2 mM or
5.5 mM glucose compared to Kir6.2[AAA]:Cx36+/+ and
WT controls (Fig. 5A and B). Significant elevation of
insulin secretion was measured at 8 mM and 11mM
glucose, but not at 20mM glucose (Fig. 5A), and insulin
content was not significantly different (Fig. 5C). GSIS
in dissociated β-cells from Kir6.2[AAA]:Cx36+/+ or
Kir6.2[AAA]:Cx36−/− islets was also not significantly
different (Fig. 5D), consistent with the pattern previously
reported for Kir6.2[AAA] cells (Rocheleau et al. 2006).
Thus in intact Kir6.2[AAA] islets, the substantially
elevated [Ca2+]i at low (2–6mM) glucose caused by an
elimination of Cx36 gap junction coupling does not lead
to a significant elevation in insulin secretion. Elevated
insulin secretion does occur, however, in dissociated
β-cells at low glucose, as well as in intact islets at
moderately higher glucose levels.
Gap junction-independent suppression of insulin by
cell–cell contact is cAMP and PKA dependent
We then asked what molecular events underlie the
gap-junction independent suppressionof insulin secretion
in intact Kir6.2[AAA]:Cx36−/− islets at 2 mMglucose? The
suppression still occurs despite a large elevation in [Ca2+]i,
suggesting that a step distal to [Ca2+]i elevation in GSIS
is involved. A number of Ca2+-independent pathways
underlying insulin secretion regulate the trafficking and
exocytosis of insulin granules at the plasma membrane
(Henquin, 2000), including elevated cAMP (Wang &
Thurmond, 2009). To test whether a step distal to
[Ca2+]i is involved, we elevated cAMP in Kir6.2[AAA]
islets by applying 3-isobutyl-1-methylxanthine (IBMX;
100μM) and forskolin (50μM). At 2mM glucose, insulin
secretion was suppressed in Kir6.2[AAA]:Cx36+/+ islets.
There was a significant elevation in insulin secretion
from Kir6.2[AAA]:Cx36−/− islets (Fig. 6A), approaching
that seen at 20mM glucose and correlating with the
measured [Ca2+]i changes in these islets. Application of
the GLP1-receptor (GLP1R) agonist exendin4 (100 nM,
Tocris Bioscience, Ellisville,MO,USA),which raises cAMP
levels by Gs activation of adenyl cyclase, also led to an
elevation of insulin secretion at 2 mM glucose, but only in
Kir6.2[AAA]:Cx36−/− islets (Fig. 6B). To test for potential
alterations in the sensitivity of Ca2+-triggered insulin
secretion which could also explain the Ca2+-independent
suppression, we maximally elevated [Ca2+]i using high
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KCl (+30mM). This led to a similar elevation in insulin
secretion in both sets of islets (Fig. 6C).
The high KCl treatment was associated with a sub-
stantial elevation in [Ca2+]i in bothKir6.2[AAA]:Cx36+/+
and Kir6.2[AAA]:Cx36−/− islets (Fig. 6D). However,
cAMP elevations induced by IBMX and forskolin
led to a very small elevation in [Ca2+]i in the
Kir6.2[AAA]:Cx36−/−− islets, and exendin4 treatment
had no significant effect on [Ca2+]i (Fig. 6D). We also
measured insulin secretion in Cx36+/+, Cx36+/−, or
Cx36−/− islets (Kir6.2 wild-type) treated with IBMX and
forskolin. At 5.5 mM, but not 2 mM glucose, there was
increased insulin secretion in the Cx36−/− islets compared
to Cx36+/+ islets (Fig. 6E), again correlating with the
measured [Ca2+]i changes in these islets (Fig. 1).
We then used two different approaches to determine
the target of cAMP that enables the β-cells to
overcome the suppression of Ca2+-triggered insulin
secretion at low glucose. First, we applied cAMP
analogues specific to either protein kinase A (PKA)
or exchange protein activated by cAMP 2 (Epac2),
the major targets of cAMP in the β-cell. Application
of the PKA-specific agonist 6-Bnz-cAMP (300μM,
Sigma) produced a significant elevation of insulin
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Figure 4. Gap junction-dependent [Ca2+]i in Kir6.2[AAA] islets
A, mean percentage of cells displaying dynamic changes in [Ca2+]i as a function of glucose stimulation, for islets
isolated from Kir6.2[AAA]:Cx36+/+ (black squares), Kir6.2[AAA]:Cx36−/− (open squares), Kir6.2[WT]:Cx36+/+
(wild-type, grey diamonds) mice. Data averaged over n = 5 mice. ∗∗Significant difference of P < 0.01 (Student’s
unpaired t test) at each glucose concentration comparing Kir6.2[AAA]:Cx36+/+ and Kir6.2[AAA]:Cx36−/−
data. B, mean percentage of islet cells displaying dynamic changes in [Ca2+]i at 2 mM glucose,
for intact Kir6.2[WT]:Cx36+/+ (hatched), Kir6.2[AAA]:Cx36+/+ (black), Kir6.2[AAA]:Cx36+/− (grey), and
Kir6.2[AAA]:Cx36−/− (white) islets. Data averaged over n = 6 mice. ∗Significant difference of P < 0.05 and
‘ns’, non-significant difference (P > 0.05), comparing each experimental group as indicated. C, mean [Ca2+]i
concentration as a function of glucose stimulation for intact Kir6.2[AAA]:Cx36+/+ islets (black bars) and
Kir6.2[AAA]:Cx36−/− islets (white bars). Data averaged over n = 3 mice. ∗Significant difference of P < 0.05
(Student’s paired t test) comparing each experimental group as indicated. D, mean percentage of cells, dissociated
from Kir6.2[AAA]:Cx36+/+ islets, displaying dynamic changes in [Ca2+]i as a function of glucose stimulation
for GFP positive cells (open triangles) and GFP negative cells (grey triangles). E, as in D for cells dissociated from
Kir6.2[AAA]:Cx36−/− islets. Data in D and E averaged over n = 4 experiments, from 2 mice. ∗Significant difference
of P < 0.05 (Student’s unpaired t test) at each glucose concentration comparing GFP positive and GFP negative
cells.
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secretion from Kir6.2[AAA]:Cx36−/− islets (Fig. 6F), but
no elevation was observed upon application of the
Epac-specific agonist 8-Me-2-O-pCPT-cAMP (300μM,
Biolog, Bremen, Germany). In each case, insulin secretion
fromKir6.2[AAA]:Cx36+/+ islets was unchanged. Second,
the PKA antagonist H89 (10μM) and the specific PKA
antagonist Rp-cAMP (100μM, Biolog) both reduced
the exendin4-dependent elevation in insulin secretion
in Kir6.2[AAA]:Cx36−/− islets (Fig. 6G). Application
of brefeldin A (100μM), previously used as an Epac
inhibitor (Zhong & Zucker, 2005), has no effect on the
exendin4-dependent elevation of insulin secretion at low
glucose. Thus at low glucose, elevated cAMP acting via
PKA, leads to elevated insulin secretion only in the absence
of gap junction electrical coupling, and only when this
absence of electrical coupling leads to elevated [Ca2+]i.
Discussion
The ability of cells to communicate with one another
in the intact islet of Langerhans is important for the
enhancement and coordination of glucose-stimulated
insulin secretion (GSIS), as well as for the uniform
suppression of insulin secretion at low glucose. Gap
junction coupling coordinates the dynamics underlying
GSIS, and canmediate the suppressionof electrical activity
induced in a population of islet β-cells. We asked whether
gap junction coupling alone mediates a suppression
of electrical activity in intact islets, and whether this
impacts insulin secretion at low glucose. To account for
other mechanisms that could be suppressing basal insulin
secretion, we compared islets that lack functional gap
junction coupling (Cx36−/−) with dissociated β-cells that
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Figure 5. Insulin secretion in Kir6.2[AAA]:Cx36−/− islets
A, glucose-stimulated insulin secretion from isolated islets of Kir6.2[AAA]:Cx36+/+ mice (black squares) and
Kir6.2[AAA]:Cx36−/− mice (open squares). Data averaged over n = 7 mice. ∗Significant difference of P < 0.05
(Student’s paired t test) at each glucose concentration comparing Kir6.2[AAA]:Cx36+/+ and Kir6.2[AAA]:Cx36−/−
data. B, insulin secretion at 2 mM glucose, for intact Kir6.2[WT]:Cx36+/+ (hatched), Kir6.2[AAA]:Cx36+/+ (black),
Kir6.2[AAA]:Cx36+/− (grey), and Kir6.2[AAA]:Cx36−/− (white) islets. Data are expressed as a percentage of insulin
secretion in Kir6.2[AAA]:Cx36+/+ islets at 20 mM glucose to facilitate comparison with Fig. 4B. ‘ns’ indicates
non-significant difference (P > 0.05) comparing each experimental group to Kir6.2[AAA]. C, insulin content of
Kir6.2[AAA]:Cx36+/+ and Kir6.2[AAA]:Cx36−/− islets. Data averaged over n = 7 mice. D, glucose-stimulated
insulin secretion from dissociated Kir6.2[AAA]:Cx36+/+ (grey triangles) and Kir6.2[AAA]:Cx36−/− (open triangles)
β-cells. Displayed is the fractional insulin secretion per hour normalized by insulin content. Data averaged over
n = 6 mice. The difference in means ± 95% confidence interval for A and C is shown in Fig. S2C.
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Figure 6. Gap junction-independent regulation of insulin secretion in Cx36−/− islets
A, insulin secretion from isolated islets of Kir6.2[AAA]:Cx36+/+ (black bars) and Kir6.2[AAA]:Cx36−/− (white bars)
mice. Islets were incubated at 2 mM glucose (2G), plus the cAMP raising agents IBMX and forskolin (+IBMX/Fsk,
100 μM and 50 μM, respectively), or with 20 mM glucose (20G). Data averaged over n = 5 littermate mouse pairs.
B, insulin secretion from isolated islets, as in A, plus the GLP1R agonist exendin4 (100 nM). Data averaged over
n = 7 littermate mouse pairs. C, insulin secretion from isolated islets as in A, plus high KCl (+KCl, +30 mM).
Data averaged over n = 5 littermate mouse pairs. D, mean [Ca2+]i concentration in isolated islets, treated with
2 mM glucose alone, or plus IBMX and forskolin, exendin4 (+Ex4), or high KCl, as in A–C. Data averaged over
n = 3 mice. E, insulin secretion from isolated islets of Cx36+/+ (black bars), Cx36+/− (grey bars), Cx36−/− (white
bars) mice, incubated at 2 mM or 5.5 mM glucose alone (2G, 5G), plus IBMX and forskolin (+IBMX/Fsk, 100 μM
and 50 μM, respectively), or at 20 mM glucose alone (20G). Data averaged over n = 4 littermate mice. F, insulin
secretion from islets, as in A, plus either the Epac-specific cAMP analogue 8-pCPT-2-O-Me-cAMP (8-pCPT, 300 μM)
or the PKA-specific cAMP analogue 6-Bnz-cAMP (6-Bnz, 300 μM). Data averaged over n = 7 littermate mice pairs.
G, insulin secretion from isolated islets of Kir6.2[AAA]:Cx36−/− mice incubated at 2 mM glucose plus exendin4
alone (Ex4, 100 nM) or exendin4 plus either the Epac inhibitor brefeldin A (BFA, 100 μM), the PKA antagonist H89
(10 μM) or the specific PKA antagonist Rp-cAMP (100 μM). Data averaged over n = 8 mice. ∗Significant difference
of P < 0.05, ∗∗∗significant difference of P < 0.001, ‘ns’, non-significant difference (P > 0.05) (Student’s paired
t test), comparing each experimental group as indicated, or compared to 2 mM glucose alone (in D and F indicated
within the bar).
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Figure 7. How multiple cell–cell communication mechanisms
regulate basal insulin release
A, two representative cells in an islet have different threshold for
glucose activation of Ca2+-signalling, either intrinsic to the cell as
illustrated here, or induced by mosaic Kir6.2[AAA] expression. At
basal glucose levels, one cell (upper, dark grey) has reduced KATP
channel activity making it more excitable. The other cell (lower, light
grey) has increased KATP channel activity making it less excitable.
Cx36 gap junction coupling mediates a hyperpolarizing current (IK)
to the more excitable cell, preventing transient depolarization and
voltage-gated calcium channel activation. This suppresses any
[Ca2+]i elevations and Ca2+ triggering of insulin secretion in the
more excitable cell. More distal, other juxtacrine mechanisms
(‘Juxtacrine’) putatively including EphA forward signalling and
NCAM signalling also suppress insulin granule trafficking and/or
exocytosis to additionally suppress insulin secretion. B, in the
absence of gap junctions, the more excitable cell depolarizes and
elevates [Ca2+]i, but an elevation in insulin secretion is still blocked
downstream of Ca2+ signalling, dependent on other juxtacrine
mechanisms. C, cAMP acting via PKA overcomes the effect of other
lack any cellular proximity. We also utilized islets with
alteredKATP channel activity, inwhichelevations in [Ca2+]i
and insulin release are suppressed in the intact islet but
not isolated β-cells. Together, these experiments allow us
to specifically quantify the relative role of gap junctions
in regulating and suppressing basal electrical activity and
insulin secretion.
Gap junctions alone suppress basal excitability and
enhance glucose-stimulated excitability
The near total elimination of junctional conductance by a
Cx36 deletion indicates a lack of functional gap junction
coupling between β-cells. The spontaneous [Ca2+]i bursts
which emerge in a subpopulation of β-cells at low
glucose indicates a variation between cells (heterogeneity)
in the threshold at which glucose stimulates [Ca2+]i.
Similar heterogeneity in [Ca2+]i oscillations occurs in
both dissociated β-cells (Zhang et al. 2003) and islets
lacking gap junctions (Ravier et al. 2005; Benninger et al.
2008). Therefore β-cells within the islet are intrinsically
heterogeneous in terms of the electrical response to
glucose, and gap junction acts to uniformly suppress
any subthreshold response. A distribution for the glucose
threshold for [Ca2+]i bursting can be interpolated
from the response (Fig. 1B), a median of ∼5mM, with
lower/upper quartiles of ∼3.5 mM/∼9mM, respectively.
Although significant data exist on the heterogeneities of
isolated β-cells (Pipeleers, 1992; Vanschravendijk et al.
1992; Bennett et al. 1996; Zhang et al. 2003; Wojtusciszyn
et al. 2008), it remains to be determined whether this
heterogeneity arises from a variation between β-cells in
ATP-synthesis, KATP channel density, or other factors.
The similar [Ca2+]i response to glucose in Cx36−/−
islets and isolated β-cells suggests gap junctions are the
predominant mechanism present to suppress elevations
in basal [Ca2+]i that rise due to cellular heterogeneity. We
quantitatively confirm this in Cx36−/− islets that express
a loss-of-function KATP channel mutation: the elevated
[Ca2+]i at low glucose is similar to the penetrance of the
Kir6.2[AAA] transgene and similar to the elevated [Ca2+]i
in isolated β-cells from these islets (Fig. 4). We therefore
extend the previous model (Rocheleau et al. 2006) to
normal islets whereby gap junctions alone overcome the
intrinsic β-cell heterogeneity such that the less-excitable
suppressive juxtacrine mechanisms, but in the presence of gap
junction coupling a suppression of any [Ca2+]i elevation prevents an
elevation in insulin secretion. D, only when gap junction coupling is
inhibited and other juxtacrine mechanisms are overcome by cAMP
via PKA do more excitable cell show elevated Ca2+-triggering and
elevated basal insulin secretion as in isolated cells.
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cells act to suppress themore-excitable cells and uniformly
control the overall electrical response across the islet.
In the absence of Cx36, the heterogeneity in [Ca2+]i
oscillations means that some β-cells exhibit transient
repolarizing events even at high glucose; in contrast to the
sustained elevation in [Ca2+]i in the presence ofCx36.This
can explain the decrease in mean [Ca2+]i concentration
at high glucose stimulation in the absence of Cx36, and
points to the role of gap junctions to also maximize the
[Ca2+]i response.
Redundancy in how cell–cell communication
suppresses basal insulin secretion
Despite the elevations in [Ca2+]i at low glucose following a
deletion of Cx36, there is no elevation in insulin secretion.
This is in contrast to the elevated basal insulin secretion
(and lower dynamic range) observed in dissociated
β-cells. Thus,mechanisms dependent on cell–cell contacts
within the islet robustly suppresses insulin secretion at
low glucose independent of gap junction coupling and
associated [Ca2+]i elevations. The divergence between
basal [Ca2+]i and insulin secretion is most striking in
the KATP loss-of-function islets lacking gap junctions (see
Figs 4B and5B),whichmakes these an idealmodel to study
the physiological gap junction-independent suppression
of insulin secretion (see below).
Elevating cAMP levels under low glucose conditions
causes a rise in insulin secretion in the absence of
Cx36, but negligibly in the presence of Cx36. This
result demonstrates that gap junctions can robustly
suppress elevations in basal insulin secretion induced by
secretagogues that act independent of Ca2+. Importantly,
these data suggest that GLP1 or exendin-4 based
treatments to elevate islet cAMP (Lovshin & Drucker,
2009) will be less effective for enhancing islet function
in diabetic individuals when gap junction coupling is
also dysregulated: the cAMP-induced insulin secretion
at low glucose will reduce the dynamic range of the
glucose-dependent insulin secretion.
The lack of suppression of basal insulin secretion in
the absence of Cx36 following elevated cAMP (Fig. 6)
suggests that cAMP, mediated by PKA, is overcoming
the gap junction-independent coupling mechanisms that
normally suppress insulin secretion. Since no further
change in [Ca2+]i is measured upon these treatments
(Fig. 6D), the suppressive effect at low glucose acts distal
to Ca2+ triggering, likely at the level of trafficking and/or
exocytosis of insulin granules (Wang&Thurmond, 2009).
This is consistent with other juxtacrine mechanisms that
can regulate insulin granule trafficking at elevated glucose,
such as EphA–ephrinA (Konstantinova et al. 2007) and
NCAM (Olofsson et al. 2009). Interestingly, under basal
glucose conditions little or no elevations in insulin release
were observed in those studies upon a disruption of EphA
or NCAM signalling, despite altered F-actin stability, and
in contrast to substantial changes that occurred at elevated
glucose. We can account for this since the presence of
gap junction coupling would still suppress basal [Ca2+]i
elevations and thus insulin release, in a similar manner
to when cAMP is elevated. Furthermore, EphA signalling
can regulate Rac1 activity (Konstantinova et al. 2007), a
key component of the exocytotic machinery that can also
be regulated by cAMP and PKA (O’Connor & Mercurio,
2001; Li et al. 2004). Therefore elevated PKA would over-
come any suppressive ability of EphA5 signalling. We
conclude there is a redundancy in the action of cell–cell
communication in suppressing insulin secretion at low
glucose levels, with other mechanisms likely acting to
regulate steps in insulin granule trafficking and exoctyosis.
The elevated insulin secretion at moderate elevations
in glucose (8–11mM) in Kir6.2[AAA]:Cx36−/− islets
suggests that other suppressive mechanisms diminish
as glucose levels rise. Furthermore, in isolated islets
expressing gain-of-functionKATP channels, at high glucose
modulation of gap junctions alone can elevate [Ca2+]i
and insulin secretion (Benninger et al. 2011). These
data are also consistent with the suppressive action of
EphA–ephrinA (Konstantinova et al. 2007) being glucose
dependent.
Summary
We summarize in Fig. 7 how mechanisms dependent
on cell–cell contact suppresses insulin secretion at low
glucose with a robust dual regulation. Due to intrinsic
β-cell heterogeneity, some of the cells will have elevated
excitability. In the absence of any cell–cell contact these
β-cells exhibit elevated [Ca2+]i and insulin secretion at
low glucose. In the intact islet, gap junctions suppress
elevations in [Ca2+]i by coupling hyperpolarizing currents
from the less-excitable β-cells to the more-excitable
β-cells (Fig. 7A). In addition, other juxtacrinemechanisms
dependent on cell–cell contact suppress insulin secretion
by regulating insulin granule trafficking and/or exocytosis.
In the absence of gap junctions, which leads to elevated
basal [Ca2+]i, other juxtacrine mechanisms still suppress
insulin release at the level of exocytosis (Fig. 7B). Upon
elevated cAMP, mediated by PKA, which overcomes
other suppressive juxtacrine mechanisms and promotes
exocytosis, gap junctions still control the suppression
of basal insulin release via suppressing Ca2+ triggering
(Fig. 7C). Only in the absence of Cx36 gap junctions and
elevated cAMP/PK, which overcomes other suppressive
juxtacrine mechanisms, do cells in the intact islet behave
like dissociated β-cells (Fig. 7D).
Cell–cell communication can regulate hormone
secretion in other neuroendocrine cellular systems (e.g.
Bonnefont et al. 2005; Asa & Tannenbaum, 2006; Ojeda
et al. 2006; Colomer et al. 2008). Similar multicellular
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mechanisms could also be present in these systems and
play a role in regulating the response of a wide range of
hormone secretions.
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